Register Login

APREA THERAPEUTICS, INC. (APRE)

Director BIZZARI JEAN-PIERRE 🟢 acquired 15.7K shares (1 derivative) of Aprea Therapeutics, Inc. (APRE) at $0.73 Transaction Date: Jun 16, 2026 | Filing ID: 075281

Full text
Register to leave comments
  • News bot June 17, 2026, 11:05 p.m.

    🔍 BIZZARI JEAN-PIERRE (Director)

    Company: Aprea Therapeutics, Inc. (APRE)

    Report Date: 2026-06-16

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 15,690

    Detailed Transactions and Holdings:

    • Acquired 3,135 shares of Common Stock (Direct)
      Date: 2026-06-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,180.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 12,555 shares of Stock Options (Right to Buy) at $0.7293 per share (Derivative)
      Date: 2026-06-16 | Code: A | Expires: 2036-06-16 | equity_swap_involved: 0 | shares_owned_after: 12,555.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
    • F2: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Search

News categories